Blood Screening Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Blood Screening Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Blood Screening Market Size During the Forecast Period?
The market size for blood screening has seen robust growth in the past few years. Projected to increase from $3.15 billion in 2024 to $3.45 billion in 2025, the market will expand at a compound annual growth rate (CAGR) of 9.6%. The significant growth witnessed in the earlier period can be credited to increased needs for blood transfusion, a growing number of transmissible diseases, government policies and standards, a rise in blood donations and collections, and worldwide health concerns and pandemics.

In the coming years, a swift escalation is anticipated in the market size of blood screening, elevating it to $5.37 billion in 2029 with a compound annual growth rate (CAGR) of 11.7%. Factors contributing to this surge during the forecast period include advancements in the healthcare infrastructure, public health awareness initiatives, progress in infectious disease diagnostics, concerns about global health, and readiness for pandemics. Remarkable trends predicted during this period feature an increase in infectious diseases, efficiency and automation, growing demands for blood transfusions, emphasis on the safety of transfusions, and research into pathogen detection.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

What Are the High-Growth Segments in the Blood Screening Market?
The blood screening market covered in this report is segmented -

1) By Product: Reagents And Kits, Instruments, Software And Services
2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)
3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:
1) By Reagents And Kits: Diagnostic Reagents, Testing Kits
2) By Instruments: Automated Analyzers, Manual Testing Equipment
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

What Key Drivers Are Expected to Influence Future Blood Screening Market Growth?
The escalated frequency of infectious diseases is projected to stimulate the expansion of the blood screening market in the imminent future. A common practice incorporates the inspection of blood for indications of ailments by seeking a distinctive antibody produced in response to the infectious pathogen, which guides the healthcare provider in managing infectious diseases and curtailing further infection propagation in patients and transmission from individual to individual. For example, as per the data from the National Center for Biotechnology Information, a US government agency, the frequency of infectious diseases in outpatient care has seen a nearly threefold rise in two decades, growing from 8 to 26 per 1,000 in June 2022. Consequently, the surge in the frequency of infectious diseases is steering the growth of the blood screening market.

Which Companies Hold the Largest Share Across Different Blood Screening Market Segments?
Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

What Trends Are Driving Growth in The Blood Screening Market?
Top firms in the blood screening market are creating advancements like liquid biopsy to bolster early identification of cancer, enhance the monitoring of treatment, and facilitate personalized medicine tactics. Liquid biopsy is a non-invasive examination that inspects blood or other bodily fluids for cancerous cells or tumor-derived genetic matter. For instance, Guardant Health, Inc., a biotechnology corporation based in the US, in November 2023, introduced Shield, a blood-based screening examination. The Shield assessment examines cell-free DNA (cfDNA) present in the blood, which could signal the existence of colorectal tumors or pre-cancerous developments. It specifically investigates alterations in DNA fragments dispensed into the blood from cancer cells.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

What Are the Emerging Geographies for The Blood Screening Market Growth?
North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Blood Screening Market?
2. What is the CAGR expected in the Blood Screening Market?
3. What Are the Key Innovations Transforming the Blood Screening Industry?
4. Which Region Is Leading the Blood Screening Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.